Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Notes underwriting agrmnt
Appointed director
Employment agrmnt
|
|
NURX PHARMACEUTICALS, INC. (NUXP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/23/2010 |
8-K
| Quarterly results |
| 11/19/2010 |
SC 13D/A
| Dyva Holding Ltd reports a 17.8% stake in NuRx Pharmaceuticals, Inc. |
| 10/20/2010 |
8-K
| Form 8-K - Current report |
| 08/23/2010 |
10-Q
| Quarterly Report for the period ended June 30, 2010 |
| 08/16/2010 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 08/12/2010 |
4
| Padma-Nathan Harin (CEO) has filed a Form 4 on NURX PHARMACEUTICALS, INC.|
Txns:
| Granted 500,000 options to buy
@ $0.11, valued at
$55k
|
|
| 08/12/2010 |
4
| GERSHICK STEVEN (Chief Financial Officer) has filed a Form 4 on NURX PHARMACEUTICALS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.11, valued at
$5.5k
|
|
| 08/12/2010 |
8-K
| Form 8-K - Current report |
| 07/22/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/22/2010 |
8-K
| Termination of a Material Definitive Agreement |
| 05/14/2010 |
10-Q
| Quarterly Report for the period ended March 31, 2010 |
| 05/07/2010 |
SC 13D/A
| Padma-Nathan Harin reports a 21% stake in NuRx Pharmaceuticals, Inc. |
| 05/03/2010 |
SC 13D
| Baradaran Sharyar reports a 26.6% stake in NuRx Pharmaceuticals, Inc. |
| 05/03/2010 |
SC 13D
| Padma-Nathan Harin reports a 21% stake in NuRx Pharmaceuticals, Inc. |
| 04/22/2010 |
4
| Baradaran Sharyar (Director) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 04/22/2010 |
4
| Padma-Nathan Harin (CEO) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 03/31/2010 |
10-K/A
| Annual Report for the period ended September 30, 2009 [amend] |
| 02/24/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/24/2010 |
4
| Baradaran Sharyar (Director) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 02/24/2010 |
4
| Padma-Nathan Harin (CEO) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 02/24/2010 |
4
| LeBel Carl (Director) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 02/24/2010 |
4
| ROSENTHALE MARVIN E (Director) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 02/24/2010 |
3
| LeBel Carl (Director) has filed a Form 3 on NURX PHARMACEUTICALS, INC. |
| 02/24/2010 |
3
| ROSENTHALE MARVIN E (Director) has filed a Form 3 on NURX PHARMACEUTICALS, INC. |
| 02/16/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2010 |
10-Q
| Quarterly Report for the period ended December 31, 2009 |
| 02/09/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/01/2010 |
4
| GERSHICK STEVEN (CFO) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 01/29/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 01/29/2010 |
8-K
| Form 8-K - Current report |
| 01/28/2010 |
10-K/A
| Annual Report for the period ended September 30, 2009 [amend] |
| 01/28/2010 |
8-K
| Resignation/termination of a director |
| 12/29/2009 |
10-K
| Annual Report for the period ended September 30, 2009 |
| 11/27/2009 |
8-K/A
| Form 8-K - Current report [amend] |
|
|
|